Beatrice Schuler-Thurner

6PUBLICATIONS
22CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 09, 2024
Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy.

Christopher Lischer, Martin Eberhardt, Cindy Flamann

|Feb 15, 2022
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity.

Elias A T Koch, Anne Petzold, Anja Wessely

|Jul 20, 2021
Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Patterns of Response and Survival According to the Presence of Hepatic and Extrahepatic Metastasis.

Elias A T Koch, Anne Petzold, Anja Wessely

|Jul 02, 2021
Nectin-1 Expression Correlates with the Susceptibility of Malignant Melanoma to Oncolytic Herpes Simplex Virus In Vitro and In Vivo.

Barbara Schwertner, Georg Lindner, Camila Toledo Stauner

|Aug 21, 2019
Clinical-Scale Production of CAR-T Cells for the Treatment of Melanoma Patients by mRNA Transfection of a CSPG4-Specific CAR under Full GMP Compliance.

Manuel Wiesinger, Johannes März, Mirko Kummer

|May 30, 2019
Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer.

Bianca Simon, Dennis C Harrer, Beatrice Schuler-Thurner

Pageof 1

Frequent Collaborators

2 joint publications

Jan Dörrie

2 joint publications

Anja Wessely

2 joint publications

Markus V Heppt

2 joint publications

Jessica C Hassel